Skip to main content
. 2019 Apr 24;13:399. doi: 10.3389/fnins.2019.00399

Table 3.

Changes in standard verbal paired-associate learning (S-PA) and clinical assessment for attention (CAT) tests.

Group Week 6 p Week 12 p
S-PA
Unrelated pairs (1st) Placebo
Whey peptide
−0.15 ± 2.23
−0.39 ± 2.65
0.616 0.30 ± 2.23
0.57 ± 2.43
0.561
Unrelated pairs (2nd) Placebo
Whey peptide
−1.25 ± 2.43∗∗
−0.49 ± 2.73
0.139 0.11 ± 1.94
1.08 ± 2.93∗∗
0.051
Unrelated pairs (3rd) Placebo
Whey peptide
−0.96 ± 2.46∗∗
−0.55 ± 2.34
0.382 0.17 ± 2.35
0.55 ± 2.63
0.440
Visual cancelation task
Figure 1 – required time (s) Placebo
Whey peptide
−2.7 ± 4.3∗∗
−4.9 ± 8.7∗∗
0.106 −3.5 ± 4.4∗∗
−5.2 ± 8.1∗∗
0.192
Figure 1 – Accuracy (%) Placebo
Whey peptide
0.46 ± 2.60
0.86 ± 2.39
0.420 0.56 ± 3.22
1.14 ± 2.76∗∗
0.334
Figure 1 – Hitting ratio (%) Placebo
Whey peptide
−0.03 ± 0.42
−0.03 ± 0.24
0.992 0.03 ± 0.24
−0.03 ± 0.24
0.160
Figure 2 – required time (s) Placebo
Whey peptide
−2.1 ± 5.9
−5.9 ± 10.6∗∗
0.024 −3.6 ± 5.7∗∗
−6.8 ± 11.0∗∗
0.066
Figure 2 – Accuracy (%) Placebo
Whey peptide
−0.40 ± 3.60
0.62 ± 4.19
0.187 0.27 ± 2.24
0.86 ± 4.19
0.366
Figure 2 – Hitting ratio (%) Placebo
Whey peptide
0.04 ± 0.96
0.04 ± 0.91
0.998 0.11 ± 0.67
0.07 ± 0.88
0.834
Number “3” – required time (s) Placebo
Whey peptide
−3.0 ± 6.7∗∗
−6.3 ± 14.3∗∗
0.148 −2.8 ± 7.3∗∗
−5.5 ± 14.6∗∗
0.237
Number “3” – Accuracy (%) Placebo
Whey peptide
0.45 ± 2.26
0.12 ± 1.67
0.406 0.55 ± 2.69
0.41 ± 1.88
0.771
Number “3” – Hitting ratio (%) Placebo
Whey peptide
−0.00 ± 0.25
−0.03 ± 0.17
0.416 −0.02 ± 0.27
−0.02 ± 0.13
0.970
Japanese “ka” – required time (s) Placebo
Whey peptide
−3.6 ± 8.6∗∗
−7.2 ± 14.7∗∗
0.127 −3.3 ± 8.9∗∗
−6.1 ± 15.4∗∗
0.250
Japanese “ka” – Accuracy (%) Placebo
Whey peptide
0.65 ± 3.15
0.93 ± 2.90
0.634 1.01 ± 2.86
1.17 ± 4.43
0.827
Japanese “ka” – Hitting ratio (%) Placebo
Whey peptide
−0.05 ± 0.21
0.04 ± 0.31
0.091 −0.07 ± 0.24
0.04 ± 0.44
0.130
Auditory detection task
Accuracy (%) Placebo
Whey peptide
−1.5 ± 8.5
0.5 ± 4.8
0.149 −0.30 ± 6.6
−0.55 ± 5.7
0.838
Hitting ratio (%) Placebo
Whey peptide
4.1 ± 16.2
5.2 ± 21.6
0.763 7.9 ± 18.6∗∗
6.9 ± 16.9
0.775

Data are presented as means ± SD for placebo (n = 53) and whey peptide (n = 51) groups. Group differences were identified using unpaired t-tests. Changes from baseline were identified using Dunnet’s tests; p < 0.05 and ∗∗p < 0.01.